Vaxequity Ltd. in Cambridge, CB4 0GZ

Description

Data updated on: 01-11-2023

Vaxequity Ltd. with reg. no. 12620906 has been competing in the field for 4 years. The Private Limited Company can be contacted at Unit 204, Lab 4 Cambridge Science Park, Milton Road, Cambridge and their post code is CB4 0GZ. The firm's principal business activity number is 72190 and their NACE code stands for Other research and experimental development on natural sciences and engineering. Its most recent annual accounts describe the period up to 2022-05-31 and the latest confirmation statement was released on 2023-05-25.

According to the information we have, this specific firm was founded in 2020 and has been guided by eight directors, out of whom six (Mike R., Anders H., Tyrell R. and 3 remaining, listed below) are still in the management.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2021-05-31	2022-05-31	2023-05-31
Currency

Balance Sheet
Cash Bank On Hand	763 500	13 108 789	8 172 160
Current Assets	975 525	13 867 076	8 369 154
Debtors	212 025	758 287	196 994
Net Assets Liabilities		12 991 055	8 126 600
Other Debtors	37 176	218 895	111 299
Property Plant Equipment		828 443	749 943

Other Financial Data
Accrued Liabilities Deferred Income		179 219	65 064
Accumulated Depreciation Impairment Property Plant Equipment		23 322	345 355
Additions Other Than Through Business Combinations Property Plant Equipment			243 533
Average Number Employees During Period	5	13	16
Corporation Tax Recoverable	174 849	310 370
Creditors	127 425	1 480 214	774 610
Future Minimum Lease Payments Under Non-cancellable Operating Leases		240 056	167 729
Increase From Depreciation Charge For Year Property Plant Equipment			322 033
Net Current Assets Liabilities	848 100	12 386 862	7 594 544
Number Equity Instruments Exercisable Share-based Payment Arrangement		804 310	902 164
Number Equity Instruments Granted Share-based Payment Arrangement		1 903 533	201 077
Number Equity Instruments Outstanding Share-based Payment Arrangement		1 903 533	1 521 485
Other Creditors	20 982	1 211 509	286 634
Other Provisions Balance Sheet Subtotal		50 000	50 000
Other Taxation Social Security Payable	4 871
Prepayments Accrued Income		176 923	84 267
Property Plant Equipment Gross Cost		851 765	1 095 298
Taxation Including Deferred Taxation Balance Sheet Subtotal		174 250	167 887
Total Assets Less Current Liabilities		13 215 305	8 344 487
Trade Creditors Trade Payables	101 572	89 486	422 912
Trade Debtors Trade Receivables		52 099	1 428
Director Remuneration		112 500	142 058

Company staff

Mike R.

Role: Director

Appointed: 01 June 2023

Latest update: 30 March 2024

Anders H.

Role: Director

Appointed: 21 September 2021

Latest update: 30 March 2024

Tyrell R.

Role: Director

Appointed: 21 September 2021

Latest update: 30 March 2024

Jason D.

Role: Director

Appointed: 08 June 2020

Latest update: 30 March 2024

William W.

Role: Director

Appointed: 26 May 2020

Latest update: 30 March 2024

Robin S.

Role: Director

Appointed: 26 May 2020

Latest update: 30 March 2024

People with significant control

The companies that control this firm are as follows: Astrazeneca Uk Limited owns 1/2 or less of company shares and has 1/2 or less of voting rights. This business can be reached in Cambridge at Francis Crick Avenue, Cambridge Biomedical Campus, CB2 0AA and was registered as a PSC under the registration number 03674842. Yuk W. has substantial control or influence over the company. Adriel C. has substantial control or influence over the company.

Astrazeneca Uk Limited

Address: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, England

Legal authority Companies Act 2006

Legal form Private Limited Company

Country registered England And Wales

Place registered Uk Companies House

Registration number 03674842

Notified on 21 September 2021

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Yuk W.

Notified on 21 September 2021

Nature of control:

substantial control or influence

Adriel C.

Notified on 21 September 2021

Nature of control:

substantial control or influence

Robin S.

Notified on 26 May 2020

Ceased on 5 June 2020

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	29 February 2024
Account last made up date	31 May 2022
Confirmation statement next due date	08 June 2024
Confirmation statement last made up date	25 May 2023

Annual Accounts
Start Date For Period Covered By Report	2020-05-26
End Date For Period Covered By Report	2021-05-31
Annual Accounts
Start Date For Period Covered By Report	2022-06-01
End Date For Period Covered By Report	2023-05-31

Vaxequity Ltd.

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mike R.

Anders H.

Tyrell R.

Jason D.

William W.

Robin S.

Michael W.

Charles M.

People with significant control

Astrazeneca Uk Limited

Yuk W.

Adriel C.

Robin S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode